Cellular therapy for childhood neurodegenerative disease. Part I: rationale and preclinical studies.
Successful cellular replacement in the diseased human central nervous system (CNS) faces numerous hurdles. In this first installment of a 2-part review, the authors report on the preclinical challenges involved in preparing for a major Phase I trial investigating the safety of human neural stem cell transplantation in a lysosomal storage disorder. Specifically, they discuss choice of the ideal disease for treatment, best donor cell type and source for implantation, the in vitro and in vivo methods used to estimate safety and efficacy, the challenges to noninvasive tracking of cells after transplantation, and the unique issues related to the immunology of CNS cellular transplantation.
Guillaume
Daniel J
DJ
Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon 97239, USA.
Huhn
Stephen L
SL
Selden
Nathan R
NR
Steiner
Robert D
RD
D002648:Child; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D006801:Humans; D019636:Neurodegenerative Diseases / Q000628:therapy*; D009474:Neurons / Q000502:physiology; D033581:Stem Cell Transplantation / Q000379:methods* / Q000639:trends; D013234:Stem Cells / Q000502:physiology*